14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
8
Discovery and dimeric approach of novel Natriuretic Peptide Receptor A (NPR-A) agonists.
Asubio Pharma
7
Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model.
Asubio Pharma
15
2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.
Asubio Pharma
36
Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2a inhibitors.
Asubio Pharma
28
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design.
Asubio Pharma
1
Discovery and structure-activity relationships of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation.
Asubio Pharma
21
Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors.
Asubio Pharma
17
Benzothiophene derivatives as phosphodiesterase 10A (PDE10A) inhibitors: Hit-to-lead studies.
Asubio Pharma
22
Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
Asubio Pharma
9
Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors.
Asubio Pharma
26
Discovery and in vivo effects of novel human natriuretic peptide receptor A (NPR-A) agonists with improved activity for rat NPR-A.
Asubio Pharma
15
Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors.
Asubio Pharma
19
Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
Asubio Pharma